Financhill
Back

Vincerx Pharma Quote, Financials, Valuation and Earnings

Vincerx Pharma Price Quote

$0.34
-0.01 (-2.83%)
(Updated: October 31, 2024 at 6:55 PM ET)

Vincerx Pharma Key Stats

Sell
14
Vincerx Pharma (VINC) is a Sell

Day range:
$0.33 - $0.37
52-week range:
$0.36 - $9.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.71%

Volume:
618.4K
Avg. volume:
835.5K
1-year change:
-63.17%
Market cap:
$10.9M
Revenue:
$0
EPS:
$-1.32

How Much Does Vincerx Pharma Make?

Data Unavailable

Is Vincerx Pharma Growing As A Company?

Data Unavailable

Vincerx Pharma Stock Price Performance

  • Did Vincerx Pharma Stock Go Up Last Month?
    Vincerx Pharma share price went down by -51.13% last month
  • Did VINC's Share Price Rise Over The Last Year?
    VINC share price fell by -63.17% over the past 1 year

What Is Vincerx Pharma 52-Week High & Low?

Vincerx Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vincerx Pharma?

  • How Much Debt Does Vincerx Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vincerx Pharma Have?
    Cash and short term investments quarterly total is $16.3M
  • What Is Vincerx Pharma’s Book Value Per Share?
    Book value per share is 0.52

Is Vincerx Pharma Cash Flow Positive?

  • What Is VINC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$28.2M
  • What Is Vincerx Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $17M
  • What Is Vincerx Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $12.5M

Vincerx Pharma Return On Invested Capital

Data Unavailable

Vincerx Pharma Earnings Date & Stock Price

Vincerx Pharma Competitors

  • Who Are Vincerx Pharma's Competitors?
    Below is a list of companies who compete with Vincerx Pharma or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • CEL-SCI Corp (CVM)
    • IGC Pharma Inc (IGC)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Protalix BioTherapeutics Inc (PLX)

Vincerx Pharma Dividend Yield

Vincerx Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 1614.78%

Major Shareholders

  • How many VINC shares are owned by institutional investors?
    12.5M VINC shares are owned by institutional investors
  • How many VINC shares are owned by insiders?
    4M VINC shares are owned by insiders